{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:39:04Z","timestamp":1793144344287,"version":"4.5.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Lung League St. Gallen - Appenzell"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Nation-wide hospitalization databases include diagnostic information at the level of an entire population over an extended period of time. Comorbidity network and early disease development can be unveiled. Chronic obstructive pulmonary disease (COPD) is an underdiagnosed condition for which it is crucial to identify early disease indicators. The identification of gender-specific conditions preceding the onset of COPD may reveal disease progression patterns allowing for early diagnosis and intervention. The objective of the study was to investigate the antecedent hospitalization history of patients newly diagnosed with COPD and to retrace a gender-specific trajectory of coded entities prior to the onset of COPD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Material and methods<\/jats:title>\n<jats:p>A population-wide hospitalization database including information about all hospitalizations in Switzerland between 2002 and 2018 was used. COPD cases were extracted from the database and comorbidities occurring prior to the onset of COPD identified. Comorbidities significantly over-represented in COPD compared with a 1:1, age- and sex-matched control population were identified and their longitudinal evolution was analyzed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Between 2002 and 2018, 697,714 hospitalizations with coded COPD were recorded in Switzerland. Sixty-two diagnoses were significantly over-represented before onset of COPD. These preceding comorbidities included both well-established conditions and novel links to COPD. Early pre-conditions included nicotine and alcohol abuse, obesity and cardiovascular diseases. Later comorbidities included atrial fibrillation, diseases of the genitourinary system and pneumonia. Atherosclerotic heart diseases were more prevalent in males, whereas hypothyroidism, varicose and intestinal disorders were more frequent in females. Disease trajectories were validated using an independent data set.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Gender-specific disease trajectories highlight early indicators and pathogenetic links between COPD and antecedent diseases and could allow for early detection and intervention.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0288237","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T17:25:34Z","timestamp":1688750734000},"page":"e0288237","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gender-specific disease trajectories prior to the onset of COPD allow individualized screening and early intervention"],"prefix":"10.1371","volume":"18","author":[{"given":"Michelle","family":"Hagmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-0428","authenticated-orcid":true,"given":"Florent","family":"Baty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rassouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha T.","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Brutsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"pone.0288237.ref001","unstructured":"GOLD. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease; 2021. https:\/\/goldcopd.org\/."},{"key":"pone.0288237.ref002","unstructured":"Forum of International Respiratory Societies. The Global Impact of Respiratory Disease; 2012. https:\/\/theunion.org\/sites\/default\/files\/2020-08\/The_Global_Impact_of_Respiratory_Disease.pdf."},{"issue":"1","key":"pone.0288237.ref003","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1440-1843.2011.02073.x","article-title":"Economic burden of chronic obstructive pulmonary disease","volume":"17","author":"WS Teo","year":"2012","journal-title":"Respirology"},{"key":"pone.0288237.ref004","doi-asserted-by":"crossref","first-page":"m234","DOI":"10.1136\/bmj.m234","article-title":"Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017","volume":"368","author":"X Li","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"pone.0288237.ref005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2500\/aap.2015.36.3812","article-title":"Burden of chronic obstructive pulmonary disease: healthcare costs and beyond","volume":"36","author":"SM May","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"pone.0288237.ref006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/resp.12660","article-title":"Global burden of COPD","volume":"21","author":"JL L\u00f3pez-Campos","year":"2016","journal-title":"Respirology"},{"issue":"114","key":"pone.0288237.ref007","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1183\/09059180.00003609","article-title":"Epidemiology of COPD","volume":"18","author":"C Raherison","year":"2009","journal-title":"Eur Respir Rev"},{"issue":"5","key":"pone.0288237.ref008","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1183\/09031936.03.00031403","article-title":"What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis","volume":"22","author":"AL Hansell","year":"2003","journal-title":"Eur Respir J"},{"issue":"4","key":"pone.0288237.ref009","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.00012408","article-title":"Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD","volume":"32","author":"DM Mannino","year":"2008","journal-title":"Eur Respir J"},{"key":"pone.0288237.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-12-1","article-title":"Up-to-date on mortality in COPD\u2014report from the OLIN COPD study","volume":"12","author":"A Lindberg","year":"2012","journal-title":"BMC Pulm Med"},{"issue":"3","key":"pone.0288237.ref011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pulmoe.2018.09.006","article-title":"COPD and Cardiovascular Disease","volume":"25","author":"S Andr\u00e9","year":"2019","journal-title":"Pulmonology"},{"key":"pone.0288237.ref012","unstructured":"GOLD. Global Initiative for Chronic Obstructive Lung Disease; 2021. https:\/\/goldcopd.org\/wp-content\/uploads\/2020\/11\/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf."},{"key":"pone.0288237.ref013","unstructured":"WHO. Chronic obstructive pulmonary disease (COPD); 2017. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd)."},{"issue":"9823","key":"pone.0288237.ref014","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"M Decramer","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"pone.0288237.ref015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccm.2013.09.011","article-title":"Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease","volume":"35","author":"S Salvi","year":"2014","journal-title":"Clin Chest Med"},{"issue":"3","key":"pone.0288237.ref016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1620\/tjem.186.151","article-title":"Effects of air pollution and smoking on chronic obstructive pulmonary disease and bronchial asthma","volume":"186","author":"H Sasaki","year":"1998","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"pone.0288237.ref017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00182-2017","article-title":"Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania","volume":"51","author":"NF Magitta","year":"2018","journal-title":"Eur Respir J"},{"issue":"10","key":"pone.0288237.ref018","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/thx.2006.061457","article-title":"Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China","volume":"62","author":"S Liu","year":"2007","journal-title":"Thorax"},{"issue":"1","key":"pone.0288237.ref019","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/thx.2008.112136","article-title":"Early life origins of chronic obstructive pulmonary disease","volume":"65","author":"C Svanes","year":"2010","journal-title":"Thorax"},{"issue":"2","key":"pone.0288237.ref020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1411532","article-title":"Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease","volume":"373","author":"P Lange","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0288237.ref021","doi-asserted-by":"crossref","first-page":"e63285","DOI":"10.1371\/journal.pone.0063285","article-title":"Comorbidities and burden of COPD: a population based case-control study","volume":"8","author":"F Baty","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"pone.0288237.ref022","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00059-020-04893-4","article-title":"The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease","volume":"45","author":"A Daher","year":"2020","journal-title":"Herz"},{"key":"pone.0288237.ref023","unstructured":"GOLD. Global Initiative for Chronic Obstructive Lung Disease; 2022. https:\/\/goldcopd.org\/wp-content\/uploads\/2021\/12\/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf."},{"issue":"7","key":"pone.0288237.ref024","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1164\/rccm.201801-0168WS","article-title":"Female sex and gender in lung\/sleep health and disease. Increased understanding of basic biological, pathophysiological, and behavioral mechanisms leading to better health for female patients with lung disease","volume":"198","author":"MK Han","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"pone.0288237.ref025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.chest.2016.10.031","article-title":"Improving the Management of COPD in Women","volume":"151","author":"CR Jenkins","year":"2017","journal-title":"Chest"},{"issue":"4","key":"pone.0288237.ref026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/15412550500346501","article-title":"Cost differences for COPD with and without physician-diagnosis","volume":"2","author":"SA Jansson","year":"2005","journal-title":"COPD"},{"issue":"7","key":"pone.0288237.ref027","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1503\/cmaj.091784","article-title":"Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care","volume":"182","author":"K Hill","year":"2010","journal-title":"CMAJ"},{"issue":"4","key":"pone.0288237.ref028","doi-asserted-by":"crossref","first-page":"e0152266","DOI":"10.1371\/journal.pone.0152266","article-title":"COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study","volume":"11","author":"A Casas Herrera","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"pone.0288237.ref029","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.rmed.2006.06.027","article-title":"Early detection of COPD: a case finding study in general practice","volume":"101","author":"J Vandevoorde","year":"2007","journal-title":"Respir Med"},{"issue":"1","key":"pone.0288237.ref030","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1038\/s41598-021-84860-z","article-title":"Characterisation, identification, clustering, and classification of disease","volume":"11","author":"AJ Webster","year":"2021","journal-title":"Sci Rep"},{"key":"pone.0288237.ref031","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1038\/ncomms5022","article-title":"Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients","volume":"5","author":"AB Jensen","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0288237.ref032","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1038\/s41467-020-18682-4","article-title":"Disease trajectory browser for exploring temporal, population-wide disease progression patterns in 7.2 million Danish patients","volume":"11","author":"T Siggaard","year":"2020","journal-title":"Nat Commun"},{"key":"pone.0288237.ref033","unstructured":"American Lung Association. COPD Causes and Risk Factors; 2021. https:\/\/www.lung.org\/lung-health-diseases\/lung-disease-lookup\/copd\/what-causes-copd."},{"issue":"2","key":"pone.0288237.ref034","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1515\/folmed-2017-0018","article-title":"Chronic Obstructive Pulmonary Disease and Hepatitis C","volume":"59","author":"EV Mekov","year":"2017","journal-title":"Folia Med (Plovdiv)"},{"issue":"2","key":"pone.0288237.ref035","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.4314\/ahs.v19i2.21","article-title":"The impact of hepatitis C viremia status on lung functions in chronic hepatitis c patients","volume":"19","author":"T Bal","year":"2019","journal-title":"Afr Health Sci"},{"issue":"2","key":"pone.0288237.ref036","doi-asserted-by":"crossref","first-page":"360","DOI":"10.12669\/pjms.35.2.73","article-title":"Non-specific impairment of Lung Function on Spirometery in Patients with Chronic Hepatitis-C","volume":"35","author":"FF Zuberi","year":"2019","journal-title":"Pak J Med Sci"},{"issue":"1","key":"pone.0288237.ref037","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/15412555.2013.800854","article-title":"Hepatitis C virus infection is not an independent risk factor for obstructive lung disease","volume":"11","author":"WA Fischer","year":"2014","journal-title":"COPD"},{"issue":"2","key":"pone.0288237.ref038","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1378\/chest.123.2.596","article-title":"Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients","volume":"123","author":"H Kanazawa","year":"2003","journal-title":"Chest"},{"issue":"4","key":"pone.0288237.ref039","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1378\/chest.128.4.2882","article-title":"Hepatitis C virus and the lung: implications for therapy","volume":"128","author":"J Moorman","year":"2005","journal-title":"Chest"},{"issue":"2","key":"pone.0288237.ref040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4081\/monaldi.2004.708","article-title":"Water and sodium imbalance in COPD patients","volume":"61","author":"G Valli","year":"2004","journal-title":"Monaldi Arch Chest Dis"},{"key":"pone.0288237.ref041","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.rmed.2016.05.003","article-title":"Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations","volume":"117","author":"R Chalela","year":"2016","journal-title":"Respir Med"},{"issue":"2","key":"pone.0288237.ref042","first-page":"514","article-title":"Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320)","volume":"30","author":"SN Singh","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"pone.0288237.ref043","first-page":"416","article-title":"Amiodarone-Induced Syndrome of Inappropriate Antidiuretic Hormone: A Case Report and Review of the Literature","volume":"44","author":"GP Marcelino","year":"2019","journal-title":"P T"},{"issue":"6","key":"pone.0288237.ref044","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/15412555.2017.1383978","article-title":"Obesity in COPD: Revealed and Unrevealed Issues","volume":"14","author":"S Zewari","year":"2017","journal-title":"COPD"},{"issue":"4","key":"pone.0288237.ref045","article-title":"Association between adiposity measures and COPD risk in Chinese adults","volume":"55","author":"J Li","year":"2020","journal-title":"Eur Respir J"},{"issue":"133","key":"pone.0288237.ref046","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1183\/09059180.00007813","article-title":"Depression and anxiety in patients with COPD","volume":"23","author":"AM Yohannes","year":"2014","journal-title":"Eur Respir Rev"},{"issue":"1","key":"pone.0288237.ref047","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rmed.2005.04.003","article-title":"Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries","volume":"100","author":"G Gudmundsson","year":"2006","journal-title":"Respir Med"},{"issue":"10","key":"pone.0288237.ref048","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.rmed.2006.01.026","article-title":"Anxiety and depression in COPD patients: The roles of gender and disease severity","volume":"100","author":"F Di Marco","year":"2006","journal-title":"Respir Med"},{"key":"pone.0288237.ref049","doi-asserted-by":"crossref","first-page":"7479992","DOI":"10.1155\/2021\/7479992","article-title":"Thyroid Gland Disease as a Comorbid Condition in COPD","volume":"2021","author":"A Gumus","year":"2021","journal-title":"Pulm Med"},{"issue":"3","key":"pone.0288237.ref050","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4103\/jfmpc.jfmpc_84_17","article-title":"Prevalence of thyroid dysfunction in chronic obstructive pulmonary disease patients in a tertiary care center in North India","volume":"7","author":"SC Chaudhary","year":"2018","journal-title":"J Family Med Prim Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T17:26:12Z","timestamp":1688750772000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288237"}},"subtitle":[],"editor":[{"given":"Ramune","family":"Jacobsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288237","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]}}}